On the Nose: Reducing Nasopharyngeal Cancer-Related Mortality Using Risk-Based Epstein-Barr Virus Serology Screening

J Clin Oncol. 2025 Jan;43(1):1-3. doi: 10.1200/JCO-24-01605. Epub 2024 Oct 1.

Authors

Philip E Castle^{1

2}, Paul K J Han³

Affiliations

¹ Division of Cancer Prevention, US National Cancer Institute, Rockville, MD.
² Division of Cancer Epidemiology and Genetics, US National Cancer Institute, Rockville, MD.
³ Division of Cancer Control and Population Sciences, US National Cancer Institute, Rockville, MD.

PMID: 39353162
PMCID: PMC11663127 (available on 2026-01-01)
DOI: 10.1200/JCO-24-01605

No abstract available

Publication types

Editorial